🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To explore the efficacy and safety of vebreltinib plus platinum-doublet che...
Status
Not Yet Recruiting
Location
241 West Huaihai Road, Xuhui District, Shanghai, 200030, China.
Start Date
2026-03-30
Trial ID
NCT07549061
Treatments Being Tested
This is a prospective, cohort, multicenter study. Cohort 1 is treatment gro...
Status
Recruiting
Location
The Second Affiliated Hospital Zhejiang University School of Medicine
Start Date
2025-09-30
Trial ID
NCT07153887
Treatments Being Tested
The goal of phase Ib study was to evaluate efficacy and tolerability of the...
Status
Recruiting
Location
Ordos Central Hospital
Start Date
2025-04-08
Trial ID
NCT07087223
To assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC...
Status
Recruiting
Location
Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute
Start Date
2017-09-27
Trial ID
NCT03175224
Treatments Being Tested
This is a single-arm, exploratory phase Ib/II study with a seamless design ...
Status
Recruiting
Location
The Second Affiliated Hospital of Nanchang University
Start Date
2026-07-03
Trial ID
NCT07655622
Treatments Being Tested
According to the 2024 edition of the NCCN guidelines and the 2023 edition o...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06644313
Treatments Being Tested
Efficacy and Safety Evaluation of Vebreltinib Plus PLB1004 as the First-lin...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-08-07
Trial ID
NCT06574347
Treatments Being Tested
The main purpose of this study is to explore the feasibility of selecting t...
Status
Recruiting
Location
Tianjin Medical Unversity Second Hospital
Start Date
2024-11-01
Trial ID
NCT06739395
This is a Phase 1, open-label, multi-center, randomized, 2-period, adaptive...
Status
Unknown
Location
New Zealand Clinical Research
Start Date
2022-05-20
Trial ID
NCT05367388
This study is an open-label, randomized, controlled, multicenter Phase IIIb...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-07-07
Trial ID
NCT06930794